ADRB2 and early-onset autosomal dominant Alzheimer disease: Downregulation of the astrocytic β2-AR-pathway has been proposed to contribute to several neurological conditions such as multiple sclerosis, Alzheimer's disease, human immunodeficiency virus encephalitis, stroke, and hepatic encephalopathy (Laureys et al., 2010).